ARCHIVES

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

XIIIth International Cancer Congress in Seattle Drawing Record Numbers Or Top Scientific Program

July 30, 1982

Report Urges Enhancement Of Cancer Data Systems.

October 20, 2000

Bevacizumab And Irinotecan May Increase Survival Of GBM

October 26, 2007

Scientists Brief Writers On Progress In Cancer Research

April 11, 1975

In Brief: House Passes FY ’77 Money Bill, But Veto Seems Likely; NIH Relaxes Moonlighting Rule

August 20, 1976

Professional Societies: ONS To Study Trends In Health Economics Affecting Nursing

October 4, 1996